14/03/2019 19:00:00

Class Action Update KHC, AVEO & CVS Bronstein, Gewirtz & Grossman, LLC

NEW YORK, March 14, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

The Kraft Heinz Company (NASDAQ: KHC)

Class Period: May 4, 2017 - February 21, 2019

Deadline: April 25, 2019

For more info:www.bgandg.com/khc

The Complaint alleges that Defendants made materially false and misleading statements and/or failed to disclose that: (1) Kraft’s internal controls, specifically with respect to its procurement area, were inadequate; (2) Kraft would be forced to write down a significant amount of goodwill and certain intangible assets in its Kraft natural cheese business, its Oscar Mayer cold cuts business, and its Canada retail business due to supply chain issues; (3) Kraft failed to advise investors of the foregoing issues; and (4) as a result, Kraft’s public statements were materially false and misleading at all relevant times.

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO)

Class Period: August 4, 2016 - January 31, 2019

Deadline: April 26, 2019

For more info:www.bgandg.com/aveo

The Complaint alleges that Defendants made materially false and misleading statements and/or failed to disclose that: (1) the TIVO‑3 trial was inadequately designed to address the OS concerns regarding AVEO’s lead candidate drug, tivozanib, from the TIVO-1 trial presented in the June 2013; (2) tivozanib had insufficient survival data to meet FDA approval following its initial 2013 rejection; (3) this lack of sufficient survival data would put tivozanib at greater risk of delayed FDA approval; and (4) as a result, AVEO’s public statements were materially false and misleading at all relevant times. 

CVS Health Corporation (NYSE: CVS)

Class Period: May 21, 2015 - February 20, 2019

Deadline: April 26, 2019

For more info:www.bgandg.com/cvs

The Complaint alleges that Defendants made materially false and misleading statements and/or failed to disclose that: (1) CVS Health’s financial condition and expected earnings were deteriorating as a result of rising costs and poor results associated with the Omnicare Acquisition; and (2) as a result, CVS Health’s public statements were materially false and misleading at all relevant times.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz

212-697-6484 | info@bgandg.com

BGG Logo.jpg

Related content
18 Mar - 
Deadline Reminder: The Law Offices of Howard G. Smith R..
18 Mar - 
Deadline Reminder: The Law Offices of Howard G. Smith R..
18 Mar - 
The Klein Law Firm Reminds Investors of Class Actions o..
Related debate
08 Mar - 
KHC klarer sig rigtig godt i disse turbolente markedsda..
08 Mar - 
Er der andre end mig der lurer på KHC? Teknisk siger de..
03 Mar - 
God video, tak for den ;)
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
HPV Vaccine Mandate Ill-Advised, States Association of American Physicians and Surgeons (AAPS)
2
AzurRx BioPharma Announces Presentation on Its Positive Phase II Data in MS1819-SD in Chronic Pancreatitis at the 2019 Digestive Disease Week Conference
3
Jumio Partners with ComplyAdvantage to Reduce AML Risk Exposure
4
Global Gaming’s X2 Games Announces the Launch of Pre-Orders for its Cutting-Edge Amazon Alexa Powered Board Game St. Noire
5
BOXX Showcases Data Science Workstation and Other Solutions at GTC

Related stock quotes


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
19 March 2019 10:44:43
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20190215.1 - EUROWEB6 - 2019-03-19 11:44:43 - 2019-03-19 10:44:43 - 1000 - Website: OKAY